tiprankstipranks

Ecor1 Capital, Llc Insider Profile

4 Followers
Ecor1 Capital, Llc, Ten Percent Owner at Eiger Biopharmaceuticals, holds 15.58M shares in Zymeworks (Ticker: ZYME), holds 7.88M shares in AnaptysBio (Ticker: ANAB), holds 11.33M shares in Mersana Therapeutics (Ticker: MRSN). Most recently, Ecor1 Capital, Llc Bought ― shares of Zymeworks on Jan 15, 2025 for an estimated value of 2.28M.
tipranks
Ecor1 Capital, Llc

Ecor1 Capital, Llc
Eiger Biopharmaceuticals (EIGRQ)
Ten Percent Owner

Ranked #5,112 out of 100,285 Corporate Insiders

Profitable Transactions

57%
20 out of 35 Profitable Transactions

Average Return

+13.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$705M
43.61%
31.03%
17.29%
4.15%
3.92% Others
A breakdown of Ecor1 Capital, Llc's holdings

Insider Roles

Prothena
(PRTA)
Ten Percent Owner
Zymeworks
(ZYME)
Director, Ten Percent Owner
AnaptysBio
(ANAB)
Director, Ten Percent Owner
Tango Therapeutics
(TNGX)
Ten Percent Owner
+4 other positions
Roles that Ecor1 Capital, Llc holds in companies

Most Profitable Insider Trade

Stock:
Prothena
(PRTA)
Rating:Informative Buy
Date:May 09, 2022 - May 09, 2023
Return:+180.00%
The most profitable trade made by Ecor1 Capital, Llc

Ecor1 Capital, Llc's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EIGRQ
Eiger Biopharmaceuticals
Jun 30, 2015
Informative Buy
$24.17M
AKUS
AKOUOS
Jul 02, 2020
Uninformative Buy
$26.26M
SURF
Surface Oncology
Sep 03, 2020
Informative Sell
2.38M
$5.03M
Prothena
May 09, 2022
Ten Percent Owner
Informative Sell
30.84M
$307.45M
AnaptysBio
Jan 02, 2025
Director, Ten Percent Owner
Informative Buy
1.10M
$121.91M
Corvus Pharmaceuticals
Oct 01, 2021
Ten Percent Owner
Informative Sell
25.04M
$398.90K
Odonate
Dec 10, 2021
Ten Percent Owner
Informative Buy
308.66K
$0.00
Voyager Therapeutics
Jan 11, 2023
Ten Percent Owner
Informative Sell
7.14M
$19.99M
Zymeworks
Jan 15, 2025
Director, Ten Percent Owner
Informative Buy
2.28M
$218.73M
Tango Therapeutics
Nov 08, 2024
Ten Percent Owner
Informative Sell
8.42M
$29.23M
Mersana Therapeutics
Dec 23, 2024
Ten Percent Owner
Uninformative Sell
$7.25M
GNVC
GenVec Inc
May 27, 2014
Informative Buy
54.04K
$6.92M
List of latest transactions for each holding click on a transaction to see Ecor1 Capital, Llc's performance on stock

Ecor1 Capital, Llc insider profile FAQ

What is the percentage of profitable transactions made by Ecor1 Capital, Llc?
The percentage of profitable transactions made by Ecor1 Capital, Llc is 57%.
    What is the average return per transaction made by Ecor1 Capital, Llc?
    The average return per transaction made by Ecor1 Capital, Llc is 13.20%.
      What stocks does Ecor1 Capital, Llc hold?
      Ecor1 Capital, Llc holds: EIGRQ, AKUS, SURF, PRTA, ANAB, CRVS, ODTC, VYGR, ZYME, TNGX, MRSN, GNVC stocks.
        What was Ecor1 Capital, Llc’s latest transaction?
        Ecor1 Capital, Llc latest transaction was an Informative Buy of $2.28M.
          What was Ecor1 Capital, Llc's most profitable transaction?
          Ecor1 Capital, Llc’s most profitable transaction was an Informative Buy of PRTA stock on May 9, 2022. The return on the trade was 180.00%.
            What is Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals?
            Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.